Sameer Parikh

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BeiGene
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    MingSight Pharmaceuticals
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novalgen Limited
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Kite Pharma
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AbbVie
    Date added:
    08/21/2023
    Date updated:
    07/18/2024
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice